Original ResearchPublished 9 October 2026Cytarabine-based mobilisation yields higher CD34+ cell counts than cyclophosphamide regardless of prior daratumumab exposure in multiple myelomaWojciech Szlasa · Artur Borkowski · Monika Mordak-Domagała · Jacek Kwiatkowski · Katarzyna Malesa · Mateusz Sawicki · Jarosław DybkoFrontiers in Oncologydoi 10.3389/fonc.2026.1915658
Original ResearchPublished 7 October 2026A predictive model for cytarabine syndrome-associated febrile episodes in children with acute lymphoblastic leukemiaZheng Wu · Lixiang Zhu · Yi Liu · Fangyuan Lai · Zebin Chen · Feiqiu Wen · Huirong Mai · Xuejuan LiFrontiers in Pediatricsdoi 10.3389/fped.2026.1957986
